Latest News for ABBV

Authoritative coverage of ABBV: earnings, product launches, management updates, regulatory filings, and trusted third‑party analysis to support research and due diligence.

Quick links:Overview•Financial Metrics•Technicals•Returns•Market Cap & EV•Financials

Will AbbVie's Oncology Franchise Remain Under Pressure in Q2?

zacks.com•

6 days ago

Will AbbVie's Oncology Franchise Remain Under Pressure in Q2?

ABBV's Q2 oncology revenues may edge lower as Imbruvica weakness outweighs gains from Venclexta and newer cancer therapies.

PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors?

fool.com•

6 days ago

PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors?

PINK has stronger one-year and three-year returns, while IXJ offers lower costs and a higher dividend yield.

ABN Amro Investment Solutions Buys 105,906 Shares of AbbVie Inc. $ABBV

defenseworld.net•

6 days ago

ABN Amro Investment Solutions Buys 105,906 Shares of AbbVie Inc. $ABBV

ABN Amro Investment Solutions boosted its stake in AbbVie Inc. (NYSE: ABBV) by 80.6% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 237,318 shares of the company's stock after buying an additional 105,906 shares during the period. ABN Amro Investment Solutions'

Social Sentiment

Want to see how the market feels about ABBV? View real-time social sentiment analysis from Twitter and StockTwits to gauge crowd psychology and potential price impacts.

View Social Sentiment